Form D · Biotechnology

EquiSeq Inc.

Albuquerque, NM · CIK 0001661782

Offering snapshot reported Sep 25, 2019 · SEC filing

Reported sold
$662K
Offering amount: $1M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 19, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 25, 2019Initial$661,658No comparison6SEC filing
May 17, 2017Amendment$230,000$200,000vs Nov 30, 20163SEC filing
Nov 30, 2016Initial$30,000No comparison1SEC filing
Dec 30, 2015Initial$81,863No comparison2SEC filing

Offering details

Securities
Equity, Security to be acquired
Exemptions
04
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-349550
$611,658 in outstanding indebtedness has been converted into equity securities in connection with the offering.

Source: Form D, filed Sep 25, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Alexander Hafez Director, Executive, Promoter
Patrick Jordan Director
Alexandra Palmer Director, Executive, Promoter
Heather Sinclair Director
Paul Szauter Director, Executive, Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:
725 6 Th Street Nw
Albuquerque, NM, 87102